This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Thrombin Generation and Thromboelastography in Non-overt DIC

This study has been terminated.
(Insufficient subject enrollment)
Information provided by (Responsible Party):
Deborah Brown, The University of Texas Health Science Center, Houston Identifier:
First received: March 3, 2006
Last updated: February 6, 2013
Last verified: February 2013
Sepsis is the 13th most common cause of death in the United States, causing approximately 210,000 deaths per year. Once DIC has developed, irreversible organ injury has already occurred and the mortality rate is 70%. Inhibition of systemic coagulation with activated protein C concentrate has been the only therapy for sepsis introduced in the past several decades which has improved outcomes. Elucidation of the coagulopathic mechanisms early in the development of DIC may give rise to targeted therapies and strategies for early intervention. We hypothesize that an increase in endogenous thrombin potential precedes the development of overt DIC by a clinically significant time period. Our primary objective is to determine if endogenous thrombin potential (ETP) measured at first diagnosis of sepsis prior to the onset of DIC and organ failure is predictive of overt DIC and/or poor outcome. We will compare ETP to standard coagulation assays and the clinical assessment of DIC using the ISTH criteria for overt DIC. A secondary objective of this study is to determine if host coagulation variables predispose to the development of DIC and poor clinical outcome during sepsis.

Sepsis Disseminated Intravascular Coagulation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Use of Whole Blood and Cell-rich Coagulation Assays for the Detection of Non-Overt DIC in Sepsis

Resource links provided by NLM:

Further study details as provided by Deborah Brown, The University of Texas Health Science Center, Houston:

Primary Outcome Measures:
  • Mortality [ Time Frame: 28 days ]
    ETP will be used to predict 28 day mortality

Biospecimen Retention:   Samples Without DNA
Samples will be discarded after the study is completed.

Enrollment: 2
Study Start Date: October 2006
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients arriving in Emergency Department with sepsis (systemic inflammatory response syndrome).

Inclusion Criteria:

  • Systemic inflammatory response syndrome with known or suspected infection
  • Patient to be admitted to the hospital

Exclusion Criteria:

  • Diabetic ketoacidosis, Hemophilia, weight < 25 kg, use of hemostatic agents prior to entry.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00299949

United States, Texas
Memorial Hermann Hospital
Houston, Texas, United States, 77030
Sponsors and Collaborators
The University of Texas Health Science Center, Houston
Principal Investigator: Deborah L. Brown, M.D. The University of Texas Health Science Center, Houston
  More Information

Responsible Party: Deborah Brown, Associate Professor, Pediatrics, The University of Texas Health Science Center, Houston Identifier: NCT00299949     History of Changes
Other Study ID Numbers: HSC-MS-06-0012
Study First Received: March 3, 2006
Last Updated: February 6, 2013

Additional relevant MeSH terms:
Disseminated Intravascular Coagulation
Systemic Inflammatory Response Syndrome
Pathologic Processes
Blood Coagulation Disorders
Hematologic Diseases
Hemorrhagic Disorders
Thrombophilia processed this record on August 18, 2017